Pulmonx (LUNG) Income from Continuing Operations (2019 - 2025)
Pulmonx (LUNG) posted quarterly Income from Continuing Operations of 13957000.0 for Q3 2025, up 1.38% year-over-year from 13767300.76 in Q3 2024, and up 8.15% quarter-over-quarter from 15196000.0 in Q2 2025.
Pulmonx (LUNG) Income from Continuing Operations (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Income from Continuing Operations for 7 consecutive years, with 13957000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Income from Continuing Operations rose 1.38% year-over-year to 13957000.0; the TTM figure through Sep 2025 stood at 56738000.0 (up 0.71% YoY), while the FY2024 annual figure was 56394000.0, up 7.31% from the prior year.
- Income from Continuing Operations improved to 13957000.0 in Q3 2025 per LUNG's latest filing, from 15196000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 10181000.0 in Q3 2021 and bottomed at 16195000.0 in Q2 2023.
- Historically, Income from Continuing Operations has averaged 14133684.21 across 5 years, with a median of 14172000.0 in 2022.
- Annual changes were most pronounced in 2021 — Income from Continuing Operations slumped 163.76% — and 2024, when it advanced 13.22%.
- Pulmonx's Income from Continuing Operations stood at 12997000.0 in 2021, then dropped by 9.89% to 14283000.0 in 2022, then gained by 2.77% to 13888000.0 in 2023, then advanced by 5.41% to 13137000.0 in 2024, then retreated by 6.24% to 13957000.0 in 2025.
- Business Quant data shows LUNG's Income from Continuing Operations at 13957000.0 in Q3 2025, 15196000.0 in Q2 2025, and 14448000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Pulmonx | 97.63 Mn | 27.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -13.96 Mn |
| Jun 30, 2025 | -15.20 Mn |
| Mar 31, 2025 | -14.45 Mn |
| Dec 31, 2024 | -13.14 Mn |
| Sep 30, 2024 | -14.15 Mn |
| Jun 30, 2024 | -15.34 Mn |
| Mar 31, 2024 | -13.76 Mn |
| Dec 31, 2023 | -13.89 Mn |
| Sep 30, 2023 | -14.94 Mn |
| Jun 30, 2023 | -16.20 Mn |
| Mar 31, 2023 | -15.86 Mn |
| Dec 31, 2022 | -14.28 Mn |
| Sep 30, 2022 | -14.17 Mn |
| Jun 30, 2022 | -14.64 Mn |
| Mar 31, 2022 | -15.86 Mn |
| Dec 31, 2021 | -13.00 Mn |
| Sep 30, 2021 | -10.18 Mn |
| Jun 30, 2021 | -12.98 Mn |
| Mar 31, 2021 | -12.55 Mn |
| Dec 31, 2020 | -9.29 Mn |